USPTO serial 79412703
LAKHESYS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 7, 2026
- Examiner
- ALBANO, ASHLEY C
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with LAKHESYS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
H. David Starr
H. David Starr Muncy, Geissler, Olds & Lowe, P.C.125 S. Royal StreetAlexandria, VA 22314United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific apparatus and instruments for analysis, control and detection of biological and cellular material, namely, combination apparatus consisting of microscopes, spectrometers for laboratory use and microfluidic bioprocessors for laboratory use; microfluidic chips; programmable microfluidic chips; downloadable chemical, biological and cellular analysis software for cell manufacturing; downloadable chemical, biological and cellular database software for cell manufacturing; scientific and laboratory apparatus for pharmaceutical production and bioproduction, namely cell culture incubators for scientific use, bioreactors for cell culturing, and cell culturing vessels for laboratory use; bioreactors for laboratories; laboratory chemical reactors for pharmaceutical production | ACTIVE | — |
| 010 | Medical diagnostic apparatus and instruments for biological and cell analyses; medical diagnostic apparatus and instruments for the detection, analysis and handling of genetic material; genomic analysis apparatus for medical use; medical apparatus and instruments for detecting, analyzing and manipulating biological and cell material for medical use | ACTIVE | — |
| 042 | Biological laboratory services; design, development, installation, maintenance and rental of laboratory apparatus and instruments, namely, microfluidic cell production units, microfluidic bioprocessors and microfluidic cartridges; bioproduction services, namely, biochemical development; culturing and manufacturing cells for scientific research purposes; scientific research in the field of biology, and integrated microfluidic bio-production; biological and cell analysis and manipulation services for scientific use; scientific analysis and retrieval of data in the fields of biology and integrated microfluidic bio-production; computer platform as a service (PaaS) featuring software for cell analysis and manufacturing in the field of biology; design, development, installation, rental and maintenance of computer software in the field of bioproduction and cell production; software as a service (SaaS) featuring software for cell analysis and manufacturing in the field of biology; information services with respect to scientific research by conducting clinical trials | ACTIVE | — |
| 044 | Medical services for biological and cell analysis and manipulation for medical use; medical and health services in biology, namely, provision of health care and medical services by health care professionals; culturing and manufacturing cells for medical therapy purposes, namely, medical treatment of cancer using cultured cells; biological and cell therapy services; medical services for therapy by means of integrated microfluidic bioproduction; information services with respect to biological and cell medical therapies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ASTRAVEUS
- Other trademarks owned by ASTRAVEUS
- Other trademarks owned by ASTRAVEUS
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LAKHESYS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 12, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 12, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 7, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 4, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| May 18, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 18, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 7, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 7, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 17, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 17, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 12, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 11, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 28, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 27, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 21, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 24, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 24, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 24, 2025 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Aug 5, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 5, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 5, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 8, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 7, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 7, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 24, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 24, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 14, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 13, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 4, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 20, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 20, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 19, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |